Concord Drugs Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
36.36% Fall from 52W High
-1
TTM PE Ratio
Above industry Median
43.3
Price to Book Ratio
Low in industry
1.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-48.6
RSI
RSI is mid-range
57
MFI
MFI Overbought
77

Concord Drugs Ltd shareholding Pattern

Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
49%
Public
51%

Concord Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
3
5Day EMA
39.00
10Day EMA
38.70
12Day EMA
38.50
20Day EMA
38.10
26Day EMA
37.90
50Day EMA
38.00
100Day EMA
38.40
200Day EMA
37.50
5Day SMA
39.40
10Day SMA
38.90
20Day SMA
37.60
30Day SMA
37.40
50Day SMA
37.00
100Day SMA
40.30
150Day SMA
39.40
200Day SMA
38.30
Delivery & Volume
Resistance & Support
39.04
Pivot
Resistance
First Resistance
40.60
Second Resistance
42.05
Third Resistance
43.61
Support
First Support
37.59
Second support
36.03
Third Support
34.58
Relative Strength Index
57
Money Flow Index
76.98
MACD
0.60
MACD Signal
0.38
Average True Range
2.46
Average Directional Index
24.32
Rate of Change (21)
6.88
Rate of Change (125)
12.31
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Veerhealth Care Ltd.
-
-
-
Vivanza Biosciences Ltd.
-
-
-
Concord Drugs Ltd.
-
-
-
Murae Organisor Ltd.
-
-
-
JFL Life Sciences Ltd.
-
-
-
Vilin Bio Med Ltd.
-
-
-
Sunrest Lifescience Ltd.
-
-
-

Concord Drugs Ltd Company background

Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Read More

Concord Drugs Ltd FAQs

You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage